Rua Bioscience Ltd. Statistics
Want to see NZ:RUA full AI Analyst Report?
Rua Bioscience Ltd. (RUA) Stock Statistics & Valuation Metrics
Total Valuation
Rua Bioscience Ltd. has a market cap or net worth of NZD 11.77M. The enterprise value is NZD 10.73M.
- Market Cap
- NZD 11.77M
- Enterprise Value
- NZD 10.73M
Share Statistics
Rua Bioscience Ltd. has 452,588,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 452,588,930
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Rua Bioscience Ltd.’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -56.03%.
- Return on Equity (ROE)
- -0.79
- Return on Assets (ROA)
- -0.47
- Return on Invested Capital (ROIC)
- -56.03%
- Return on Capital Employed (ROCE)
- -0.79
- Revenue Per Employee
- 172.10K
- Profits Per Employee
- -223.98K
- Employee Count
- 15
- Asset Turnover
- 0.36
- Inventory Turnover
- 6.53
Valuation Ratios
The current PE Ratio of Rua Bioscience Ltd. is -2.60. Rua Bioscience Ltd.’s PEG ratio is -0.04.
- PE Ratio
- -2.60
- PS Ratio
- 2.68
- PB Ratio
- 2.39
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- -3.37
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, Rua Bioscience Ltd. had revenue of 2.58M and earned -3.36M in profits. Earnings per share was -0.01.
- Revenue
- 2.58M
- Gross Profit
- -1.26M
- Operating Income
- -3.37M
- Pretax Income
- -3.36M
- Net Income
- -3.36M
- EBITDA
- -2.96M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -3.02M and capital expenditures 3.02M, giving a free cash flow of 0 billion.
- Operating Cash Flow
- -3.02M
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Rua Bioscience Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -33.00%
Stock Price Statistics
- Beta
- 1.27
- 52-Week Price Change
- -7.14%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- 51.12
- Average Volume (3m)
- 86.84K
Important Dates
Rua Bioscience Ltd. upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Rua Bioscience Ltd. as a current ratio of 1.08, with Debt / Equity ratio of 41.26%
- Current Ratio
- 1.08
- Quick Ratio
- 0.88
- Debt to Market Cap
- 0.18
- Net Debt to EBITDA
- -0.41
- Interest Coverage Ratio
- -10.62
Taxes
In the past 12 months, Rua Bioscience Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Rua Bioscience Ltd. EV to EBITDA ratio is -2.36, with an EV/FCF ratio of 0.00.
- EV to Sales
- 3.15
- EV to EBITDA
- -2.36
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- -2.69
Balance Sheet
Rua Bioscience Ltd. has NZD 533.70K in cash and marketable securities with NZD 1.76M in debt, giving a net cash position of -NZD 1.22M billion.
- Cash & Marketable Securities
- NZD 533.70K
- Total Debt
- NZD 1.76M
- Net Cash
- -NZD 1.22M
- Net Cash Per Share
- NZD 0.00
- Tangible Book Value Per Share
- NZD 0.01
Margins
Gross margin is -97.58%, with operating margin of -133.38%, and net profit margin of -130.14%.
- Gross Margin
- -97.58%
- Operating Margin
- -133.38%
- Pretax Margin
- -133.08%
- Net Profit Margin
- -130.14%
- EBITDA Margin
- -133.38%
- EBIT Margin
- -133.38%
Analyst Forecast
The average price target for Rua Bioscience Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 70.82%
- EPS Growth Forecast
- 41.04%
Scores
- Smart Score
- ―
- AI Score
- 44
